Achieving system readiness for radioligand therapy in the UK: the event as it happened

Achieving system readiness for radioligand therapy in the UK: the event as it happened

On 9 September, The Health Policy Partnership (HPP) was pleased to host a webinar to launch the UK situation analysis report and policy action blueprint.
Read More
Join HPP webinar on system readiness in cancer care

Join HPP webinar on system readiness in cancer care

To coincide with ESMO 2021, The Health Policy Partnership is holding a webinar to launch the policy brief 'Fostering system readiness in cancer care'.
Read More
Register for launch of the radioligand therapy readiness assessment for the UK

Register for launch of the radioligand therapy readiness assessment for the UK

Join the The Health Policy Partnership on 9 Sept for an online event to launch the UK application of the Radioligand Therapy Readiness Assessment Framework.
Read More
Lessons learned as a radioligand therapy patient

Lessons learned as a radioligand therapy patient

In this guest blog, Josh Mailman recalls his experience of receiving radioligand therapy and the barriers to widespread access for patients.
Read More
Why a framework? The importance of a systems approach for radioligand therapy

Why a framework? The importance of a systems approach for radioligand therapy

The Radioligand Therapy Readiness Assessment Framework is a robust tool which can be used to generate information about integration of radioligand therapy into the health system.
Read More
What is our vision of readiness for radioligand therapy?

What is our vision of readiness for radioligand therapy?

Assessing current integration and readiness for radioligand therapy will help us plan for its effective use.
Read More
Radioligand Therapy Readiness Assessment Framework launched at event with esteemed speakers

Radioligand Therapy Readiness Assessment Framework launched at event with esteemed speakers

On 9 June 2021, the new Radioligand Therapy Readiness Assessment Framework was launched at an event with a panel of international and multidisciplinary experts.
Read More
Launch of the Radioligand Therapy Readiness Assessment Framework

Launch of the Radioligand Therapy Readiness Assessment Framework

Join The Health Policy Partnership on Wednesday 9 June for a webinar and an in-depth discussion on health system readiness for radioligand therapy.
Read More
New poster on radioligand therapy readiness published at virtual ESMO congress

New poster on radioligand therapy readiness published at virtual ESMO congress

The Health Policy Partnership and Professor Ken Herrmann have published a poster at the virtual European Society for Medical Oncology (ESMO) congress 2020.
Read More
Poster published at ECRD focuses on radioligand therapy in neuroendocrine neoplasms

Poster published at ECRD focuses on radioligand therapy in neuroendocrine neoplasms

The Health Policy Partnership has published a poster at the 10th European Conference on Rare Diseases & Orphan Products (ECRD).
Read More
New poster published at ENETS virtual conference

New poster published at ENETS virtual conference

The Health Policy Partnership presented a poster on radioligand therapy at the European Neuroendocrine Tumor Society (ENETS) conference.
Read More
Radioligand therapy recommendations form part of submission to Europe’s Beating Cancer Plan

Radioligand therapy recommendations form part of submission to Europe’s Beating Cancer Plan

Recommendations from the radioligand therapy policy report have formed the basis of a submission to Europe’s Beating Cancer Plan, addressing the burden of cancer in the EU.
Read More